ADVM icon

Adverum Biotechnologies
ADVM

Overview Fund Activity

92 hedge funds and large institutions have $85.9M invested in Adverum Biotechnologies in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 42 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
-6
Holders Change %
-6.12%
% of All Funds
1.46%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
13
Reduced
42
Closed
16
Calls
$2.47M
Puts
$321K
Net Calls
+$2.15M
Net Calls Change
-$2.31M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$14.2M
2
Assenagon Asset Management
2
Assenagon Asset Management
Luxembourg
$1.3M
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$1.87M
4
Invesco
4
Invesco
Georgia
$375K
5
BCM
5
Bridgeway Capital Management
Texas
$317K

Top Sellers

1
RI
1
RTW Investments
New York
$293K
2
UBS Group
2
UBS Group
Switzerland
$1K
3
CAC
3
Cowen and Company
New York
$0
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$4.63M
5
Two Sigma Advisers
5
Two Sigma Advisers
New York
$1.97M
Name Holding Trade Value Shares
Change 		Shares
Change %
CS
101
Credit Suisse
Switzerland
– -$21K -1,208 Closed
DFCM
102
Dark Forest Capital Management
Puerto Rico
– -$4K -238 Closed
CAL
103
Capital Advisors Ltd
Ohio
– -$1K -59 Closed
1 2 3 4
5